Lonsurf/Bevacizumab for Advanced Metastatic Colorectal Cancer Lonsurf/Bevacizumab for Advanced Metastatic Colorectal Cancer

Dr David J. Kerr discusses the approval of the combination of Lonsurf (trifluridine-tipiracil) and bevacizumab in the third-line treatment of advanced metastatic colorectal cancer.Medscape Oncology
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Hematology-Oncology Commentary Source Type: news